Companies › NeuroDerm
2 active drug programs in 11 registered trials: 4 Phase 3, 4 Phase 2, 2 Phase 4, 1 Phase 1; Neurology, Other, Psychiatry; next expected readout Feb 2027.
Open in Phaseline: competitors, likelihood bands and readouts Company report
| Drug | Target | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|
| IR-LD/CD | – | Phase 3 | Parkinson's Disease | Feb 2027 |
| Levodopa (ND0612) Dopamine D3 receptor agonist | DRD3 | Phase 3 | Parkinson's Disease; Freezing of Gait; Parkinson Disease; Acute Stroke … | Feb 2027 |
| Registry id | Drug | Phase | Conditions | Area | Expected readout |
|---|---|---|---|---|---|
| NCT04558112 | Levodopa (ND0612) | Phase 2 | PTSD | Psychiatry | Dec 2023 |
| NCT05463367 | Levodopa (ND0612) | Phase 2 | Opioid Use | Psychiatry | Jun 2025 |
| NCT06831500 | Levodopa (ND0612) | Phase 1 | Multi-system Atrophy - Parkinsonian Type | Neurology | Nov 2026 |
| NCT06316232 | Levodopa (ND0612) | Phase 4 | Freezing of Gait | Neurology | Dec 2026 |
| NCT04006210 | IR-LD/CD | Phase 3 | Parkinson's Disease | Neurology | Feb 2027 |
| NCT04006210 | Levodopa (ND0612) | Phase 3 | Parkinson's Disease | Neurology | Feb 2027 |
| NCT02726386 | Levodopa (ND0612) | Phase 2 | Parkinson's Disease | Neurology | Feb 2027 |
| NCT06234995 | Levodopa (ND0612) | Phase 4 | Parkinson Disease | Neurology | Sep 2027 |
| NCT05285683 | Levodopa (ND0612) | Phase 2 | Chronic Pain | Other | Dec 2027 |
| NCT03735901 | Levodopa (ND0612) | Phase 3 | Acute Stroke | Neurology | Jun 2029 |
| NCT07151378 | Levodopa (ND0612) | Phase 3 | PARKINSON DISEASE (Disorder) | Neurology | Sep 2030 |
Navamedic MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals Sichuan Jishengtang Pharmaceutical Pharmasoft Epygenix
Pipelines of the same shape: areas, drug types, target families, stage and cash runway.
Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.